ERG Parameter Modeling for Psychiatric Medication Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of reliable diagnostic tests for psychiatric disorders, particularly those based on biomarkers, which hinders accurate screening, diagnosis, stratification, and prediction of pharmacological response in patients with conditions like schizophrenia, bipolar disorder, and major depressive disorder.
Innovation Solution
The use of electroretinography (ERG) parameters, analyzed through statistical methods such as logistic regression, to identify specific biomarkers for psychiatric disorders, enabling discrimination between different groups of patients based on their response to medication and shared biological characteristics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional diagnostic methods (interviews, personality tests, self-reported experiences) are used for psychiatric disorders, then diagnosis can be obtained, but reliability and accuracy are insufficient due to etiological heterogeneity and porous boundaries between DSM categories
Solution Approach 1:
The patent replaces traditional mechanical/clinical diagnostic methods (interviews, personality tests, behavioral observations) with electrophysiological measurement systems. Specifically, it uses electroretinography (ERG) to record electrical responses from retinal cells, and electroencephalography (EEG) to record electrical activity from the brain, substituting subjective clinical assessment with objective biological signal measurement.
Solution Approach 2:
The patent changes the diagnostic parameters from behavioral and subjective metrics to electrophysiological parameters. It measures specific ERG parameters (a-wave amplitude, b-wave amplitude, implicit times) and EEG parameters (power spectral density in different frequency bands, event-related potentials) that reflect underlying neurobiological processes, thereby capturing etiological heterogeneity that traditional methods miss.
2Adaptability or versatility
If DSM categories are used for diagnosis, then classification is achieved, but the porous boundaries and etiological heterogeneity reduce the power of pharmacological and neurobiological studies
Solution Approach 1:
The patent segments patients into subgroups based on their electrophysiological profiles rather than treating DSM categories as homogeneous. It identifies distinct ERG and EEG patterns within schizophrenia, bipolar disorder, and major depressive disorder, revealing subtypes with different neurobiological characteristics that respond differently to treatments, thereby increasing study power by reducing within-group heterogeneity.
Solution Approach 2:
The patent introduces electrophysiological measurements (ERG and EEG) as intermediary biomarkers that bridge the gap between DSM clinical categories and underlying neurobiological mechanisms. These intermediaries provide objective physiological data that reflect etiological processes, enabling better stratification of patients for pharmacological and neurobiological studies.
3Ease of operation
If no biomarkers are used, then diagnosis relies on clinical assessment, but there are no valid and replicable biomarkers to identify etiological heterogeneity within DSM categories
Solution Approach 1:
The patent replaces the absence of biomarkers with concrete electrophysiological measurements. It implements ERG to measure retinal cell electrical responses and EEG to measure brain electrical activity, providing valid and replicable biomarkers that objectively identify etiological heterogeneity within DSM categories, moving from purely clinical assessment to biomarker-based diagnosis.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
ERG parameters provide accurate discrimination between psychiatric disorder groups with high sensitivity and specificity, facilitating early detection, diagnosis, prognosis, and personalized treatment strategies.
Implementation Method 1
measuring a plurality of ERG parameters, in said subjects
Data Source
Figure 1
Figure 2A~2B
Figure 2C~3A
AI summary
A method of identifying a model, based on one or more ERG parameters, that permits to discriminate between a first group of subjects and a second group of subjects that differ by at least one characteristic, wherein said first group and/or second group of subjects suffer from a psychiatric disorder or a has a predisposition thereto, said method comprising (a) measuring a plurality of ERG parameters in said subjects; (b) performing a logistic regression analysis using the plurality of ERG parameters measured to identify a model that permits to discriminate between a first group and a second group of subjects, wherein the at least one characteristic comprises the response to a psychotropic medication, and wherein said at least one characteristic comprises the response to a psychotropic medication, and wherein said first group of subjects are good responders to a psychotropic medication and said second group of subjects are poor responders to said psychotropic medication.